it is under investigation in clinical trial NCT02211079 (A Study to Assess Effect of it on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates). 
